56 results
Page 2 of 3
8-K
EX-99.1
eb1klmh8hihmbtvw
30 Mar 20
PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business Highlights
8:08am
S-3
EX-4.2
hstwk
27 Dec 19
Shelf registration
5:28pm
S-3
ijdm0jjitryavbo2x4w
27 Dec 19
Shelf registration
5:28pm
8-K
EX-99.1
tf7rzkscc7y
14 Nov 19
PhaseBio Reports Third Quarter 2019 Financial Results and Recent Corporate Progress
8:16am
8-K
EX-99.1
x56qohw hr62j
13 Aug 19
PhaseBio Reports Second Quarter 2019 Financial Results and Recent Corporate Progress
4:05pm
8-K
EX-99.1
bp44zc8onws tbh9l0w
9 May 19
PhaseBio Reports First Quarter 2019 Financial and Business Results
4:05pm
424B4
cplvtio9sc3de xncu6o
12 Apr 19
Prospectus supplement with pricing info
4:32pm
8-K
EX-10.1
tzcmyz60u 0yt
9 Apr 19
PhaseBio Announces Global License of PB1023 for the Treatment of Sarcopenia-Related Diseases to ImmunoForge
8:01am
DRS
c79c wexkf1
29 Mar 19
Draft registration statement
12:00am
10-K
vvadxt 9t2gzlgbl78
26 Mar 19
Annual report
4:45pm
10-K
EX-10.13
2hy6e3qsp
26 Mar 19
Annual report
4:45pm
10-K
EX-10.14
zdj2t 25cls
26 Mar 19
Annual report
4:45pm